EML Payments Valuation

Is A8Y1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A8Y1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate A8Y1's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate A8Y1's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A8Y1?

Key metric: As A8Y1 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A8Y1. This is calculated by dividing A8Y1's market cap by their current revenue.
What is A8Y1's PS Ratio?
PS Ratio1.5x
SalesAU$217.34m
Market CapAU$334.81m

Price to Sales Ratio vs Peers

How does A8Y1's PS Ratio compare to its peers?

The above table shows the PS ratio for A8Y1 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average21.5x
QB7 Quirin Privatbank
2.1xn/a€164.1m
DG6 DG-Gruppe
55.6xn/a€158.1m
OT8 Eleving Group
1.1x6.4%€190.9m
XTP Sino
27.2x8.4%€144.9m
A8Y1 EML Payments
1.5x2.1%€334.8m

Price-To-Sales vs Peers: A8Y1 is good value based on its Price-To-Sales Ratio (1.5x) compared to the peer average (21.5x).


Price to Sales Ratio vs Industry

How does A8Y1's PS Ratio compare vs other companies in the DE Diversified Financial Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
EBEN aifinyo
0.3xn/aUS$15.51m
EBEN aifinyo
0.2xn/aUS$13.92m
CSQ creditshelf
0.005xn/aUS$29.25k
No more companies available in this PS range
A8Y1 1.5xIndustry Avg. 2.0xNo. of Companies3PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: A8Y1 is good value based on its Price-To-Sales Ratio (1.5x) compared to the European Diversified Financial industry average (2x).


Price to Sales Ratio vs Fair Ratio

What is A8Y1's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A8Y1 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.5x
Fair PS Ratio2x

Price-To-Sales vs Fair Ratio: A8Y1 is good value based on its Price-To-Sales Ratio (1.5x) compared to the estimated Fair Price-To-Sales Ratio (2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A8Y1 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.54
€0.71
+32.6%
6.2%€0.74€0.65n/a3
Nov ’25€0.37
€0.65
+75.3%
11.7%€0.75€0.56n/a3
Oct ’25€0.35
€0.65
+86.4%
11.7%€0.75€0.56n/a3
Sep ’25€0.39
€0.62
+61.8%
11.8%€0.74€0.55n/a4
Aug ’25€0.54
€0.65
+20.7%
8.6%€0.72€0.57n/a4
Jul ’25€0.57
€0.70
+22.2%
18.6%€0.91€0.56n/a4
Jun ’25€0.56
€0.70
+24.4%
18.6%€0.91€0.56n/a4
May ’25€0.60
€0.70
+17.1%
18.6%€0.91€0.56n/a4
Apr ’25€0.72
€0.67
-7.9%
19.7%€0.90€0.54n/a5
Mar ’25€0.56
€0.62
+10.3%
12.0%€0.72€0.54n/a5
Feb ’25€0.53
€0.65
+23.5%
11.5%€0.73€0.55n/a4
Jan ’25€0.50
€0.66
+33.1%
22.0%€0.86€0.49n/a4
Dec ’24€0.50
€0.59
+18.5%
27.6%€0.84€0.39n/a5
Nov ’24€0.66
€0.59
-10.9%
27.6%€0.84€0.38€0.375
Oct ’24€0.71
€0.59
-17.7%
27.6%€0.84€0.38€0.355
Sep ’24€0.66
€0.56
-15.2%
27.0%€0.83€0.38€0.395
Aug ’24€0.49
€0.39
-20.5%
19.7%€0.49€0.26€0.545
Jul ’24€0.38
€0.43
+12.7%
25.6%€0.61€0.26€0.576
Jun ’24€0.42
€0.43
+0.4%
25.6%€0.61€0.26€0.566
May ’24€0.44
€0.43
-0.8%
27.4%€0.62€0.26€0.605
Apr ’24€0.33
€0.43
+31.6%
27.4%€0.62€0.26€0.725
Mar ’24€0.30
€0.52
+71.9%
34.1%€0.89€0.27€0.568
Feb ’24€0.39
€0.65
+64.9%
39.6%€1.20€0.41€0.538
Jan ’24€0.38
€0.76
+96.6%
40.7%€1.27€0.40€0.508
Dec ’23€0.41
€0.77
+87.3%
40.7%€1.29€0.41€0.508
Nov ’23€0.33
€0.85
+161.6%
29.7%€1.29€0.52€0.668

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies